Clinical Trial Update: THE MALABSORPTION BLOOD TEST TRIAL WILL HELP DETERMINE THE BENEFITS OF PANCREATIC ENZYME REPLACEMENT THERAPY IN PATIENTS WITH MILD TO MODERATE EXOCRINE PANCREATIC INSUFFICIENCY. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating a malabsorption blood test. The study aims to determine the potential benefits of pancreatic enzyme replacement thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exocrine Pancreatic Insufficiency
• Pancreatitis

Snippet

Sponsor: Anna Evans Phillips | Conditions: Chronic Pancreatitis, Recurrent Acute Pancreatitis | Phase 4 | Status: RECRUITING